(Q82539167)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Jian Ma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nan Shi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Cheng-Gang Jiang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yue-Zhi Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xue-Feng Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shuai Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xiao-Ling Lv

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Li-Ping Zhao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yi-Ming Shao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xian-Gang Kong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jian-Hua Zhou

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rong-Xian Shen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

20 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

96-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

HIV-1 vaccine development after STEP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Application of the polyvalent approach to HIV-1 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

The role of antibodies in HIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Cytotoxic T lymphocytes in protection against equine infectious anemia virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Virulence determinants of equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

The accuracy of reverse transcriptase from HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Live attenuated AIDS viruses as vaccines: promise or peril?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Live attenuated HIV vaccines: pitfalls and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.10.032

10.1016/J.VIROL.2010.10.032

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094511%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference